1. Home
  2. STRA vs NKTR Comparison

STRA vs NKTR Comparison

Compare STRA & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strategic Education Inc.

STRA

Strategic Education Inc.

HOLD

Current Price

$82.39

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$40.80

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
NKTR
Founded
2017
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
STRA
NKTR
Price
$82.39
$40.80
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$96.67
★ $141.40
AVG Volume (30 Days)
208.0K
★ 1.4M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 2.98%
N/A
EPS Growth
★ 15.85
N/A
EPS
★ 3.19
N/A
Revenue
★ $997,137,000.00
$307,711,000.00
Revenue This Year
$2.51
N/A
Revenue Next Year
$2.96
$36.10
P/E Ratio
$25.22
★ N/A
Revenue Growth
57.23
★ 86.00
52 Week Low
$69.70
$33.40
52 Week High
$89.73
$109.00

Technical Indicators

Market Signals
Indicator
STRA
NKTR
Relative Strength Index (RSI) 57.63 22.02
Support Level $77.55 $33.87
Resistance Level $85.36 $76.63
Average True Range (ATR) 2.20 4.10
MACD 0.46 -2.30
Stochastic Oscillator 94.72 6.55

Price Performance

Historical Comparison
STRA
NKTR

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: